The mechanism of action of the immunosuppressive drug FK-506
- 30 November 1989
- journal article
- research article
- Published by Elsevier BV in Cellular Immunology
- Vol. 124 (1), 175-181
- https://doi.org/10.1016/0008-8749(89)90121-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- FK-506 — How much potential?Immunology Today, 1989
- Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in ratsInternational Journal of Immunopharmacology, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- T‐Lymphocyte Activation: The Role of Protein Kinase C and the Bifurcating Inositol Phospholipid Signal Transduction PathwayImmunological Reviews, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987
- Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol esterNature, 1985
- Interleukin 2 mRNA induction in human lymphocytes: analysis of the synergistic effect of a calcium ionophore A23187 and a phorbol esterEuropean Journal of Immunology, 1985
- Rapid loss of sensitivity of mitogen-induced lymphocyte activation to inhibition by cyclosporin ACellular Immunology, 1984